Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective.
Udwadia
Z F
ZF
Sen
T
T
Moharil
G
G
D005260:Female; D006801:Humans; D008297:Male; D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects; D024881:Drug Resistance, Bacterial; D018432:Drug Resistance, Multiple; D007194:India; D000069349:Linezolid; D023303:Oxazolidinones / Q000008:administration & dosage / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D002986:Clinical Trials as Topic
D000081:Acetamides; D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D000069349:Linezolid; D023303:Oxazolidinones